These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31066138)

  • 1. Relevance of NAT2 genotype to anti-tuberculosis drug-induced hepatotoxicity in a Chinese Han population.
    Lu L; Tao B; Wei H; Chen H; He X; Pan H; Yang M; Yi H; Tang S
    J Gene Med; 2019 Jun; 21(6):e3096. PubMed ID: 31066138
    [TBL] [Abstract][Full Text] [Related]  

  • 2.  NAT2 genetic polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in Chinese community population.
    Lv X; Tang S; Xia Y; Zhang Y; Wu S; Yang Z; Li X; Tu D; Chen Y; Deng P; Ma Y; Chen D; Chen R; Zhan S
    Ann Hepatol; 2012; 11(5):700-7. PubMed ID: 22947533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-acetyltransferase and cytochrome P450 2E1 gene polymorphisms and susceptibility to antituberculosis drug hepatotoxicity in an Indian population.
    Mishra S; Daschakraborty S; Shukla P; Kapoor P; Aggarwal R
    Natl Med J India; 2013; 26(5):260-5. PubMed ID: 25017831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. tagSNP rs1495741 as a useful molecular marker to predict antituberculosis drug-induced hepatotoxicity.
    Chamorro JG; Castagnino JP; Musella RM; Nogueras M; Frías A; Visca M; Aidar O; Costa L; de Larrañaga GF
    Pharmacogenet Genomics; 2016 Jul; 26(7):357-61. PubMed ID: 27104815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between NR1I2 polymorphisms and susceptibility to anti-tuberculosis drug-induced hepatotoxicity in an Eastern Chinese Han population: A case-control study.
    Yang M; Pan H; Chen H; Liu W; Lu L; He X; Yi H; Tang S
    Infect Genet Evol; 2020 Sep; 83():104349. PubMed ID: 32387752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The NAT2 tag SNP rs1495741 correlates with the susceptibility of antituberculosis drug-induced hepatotoxicity.
    Ho HT; Wang TH; Hsiong CH; Perng WC; Wang NC; Huang TY; Jong YJ; Lu PL; Hu OY
    Pharmacogenet Genomics; 2013 Apr; 23(4):200-7. PubMed ID: 23407048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between BACH1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a Chinese cohort.
    Zhang H; Qian H; Tao B; Yang M; Gong J; Yi H; Tang S
    Infect Genet Evol; 2018 Dec; 66():217-221. PubMed ID: 30316884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Association of rs1495741 Single Nucleotide Polymorphism with Susceptibility of Anti-tuberculosis Drug-induced Hepatotoxicity].
    Wang MG; Zhang YZ; Zhang M; He JQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Nov; 49(6):910-913. PubMed ID: 32677403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NAT2 and CYP2E1 polymorphisms and susceptibility to first-line anti-tuberculosis drug-induced hepatitis.
    Lee SW; Chung LS; Huang HH; Chuang TY; Liou YH; Wu LS
    Int J Tuberc Lung Dis; 2010 May; 14(5):622-6. PubMed ID: 20392357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of NAT2, GST and CYP2E1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity.
    Singla N; Gupta D; Birbian N; Singh J
    Tuberculosis (Edinb); 2014 May; 94(3):293-8. PubMed ID: 24637014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A validation study of the UGT1A4 rs2011404 variant and the risk of anti-tuberculosis drug-induced hepatotoxicity in an Eastern Chinese Han population.
    Zhu J; Liu W; Zhang M; Lu L; Pan H; He X; Wang N; Yang M; Yi H; Tang S
    J Clin Pharm Ther; 2021 Oct; 46(5):1288-1294. PubMed ID: 34046917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-acetyltransferase 2 polymorphisms and risk of anti-tuberculosis drug-induced hepatotoxicity in Caucasians.
    Leiro-Fernandez V; Valverde D; Vázquez-Gallardo R; Botana-Rial M; Constenla L; Agúndez JA; Fernández-Villar A
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1403-8. PubMed ID: 22283902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP2E1, GSTM1 and GSTT1 genetic polymorphisms and susceptibility to antituberculosis drug-induced hepatotoxicity: a nested case-control study.
    Tang SW; Lv XZ; Zhang Y; Wu SS; Yang ZR; Xia YY; Tu DH; Deng PY; Ma Y; Chen DF; Zhan SY
    J Clin Pharm Ther; 2012 Oct; 37(5):588-93. PubMed ID: 22335459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slow N-acetyltransferase 2 genotype contributes to anti-tuberculosis drug-induced hepatotoxicity: a meta-analysis.
    Du H; Chen X; Fang Y; Yan O; Xu H; Li L; Li W; Huang W
    Mol Biol Rep; 2013 May; 40(5):3591-6. PubMed ID: 23277397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The associations of polymorphism of N-acetyltransferase 2 gene is associated with antituberculosis drug-induced hepatotoxicity in tuberculosis patients].
    An HR; Wu XQ; Wang ZY; Liang Y; Zhang JX
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Jan; 45(1):36-40. PubMed ID: 21418817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between CYP2E1 polymorphisms and hepatotoxicity due to anti-tuberculosis drugs: a meta-analysis.
    Sheng YJ; Wu G; He HY; Chen W; Zou YS; Li Q; Zhong L; Huang YM; Deng CL
    Infect Genet Evol; 2014 Jun; 24():34-40. PubMed ID: 24607341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of gene polymorphisms of NAT2 and NR1I2 to anti-tuberculosis drug-induced hepatotoxicity.
    Wang N; Guo S; Liu H; Ding Y; Yao R; Liu Z; Zhu H; Chen X; Yang X; Chen X; Lu Y
    Xenobiotica; 2022 May; 52(5):520-526. PubMed ID: 35723590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NAT2 and CYP2E1 polymorphisms associated with antituberculosis drug-induced hepatotoxicity in Chinese patients.
    An HR; Wu XQ; Wang ZY; Zhang JX; Liang Y
    Clin Exp Pharmacol Physiol; 2012 Jun; 39(6):535-43. PubMed ID: 22506592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between common telomere length-related genetic variations, telomere length, and risk of antituberculosis drug-induced hepatotoxicity in Chinese Han population: As assessed for causality using the updated Roussel Uclaf Causality Assessment Method.
    Chen X; Hao Z; Pan H; Liu W; Lu L; Zhang M; He X; Yi H; Tang S
    Fundam Clin Pharmacol; 2023 Aug; 37(4):858-867. PubMed ID: 36855016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of allelic and genotypic frequencies of NAT2 and CYP2E1 variants in Moroccan population.
    Guaoua S; Ratbi I; Laarabi FZ; Elalaoui SC; Jaouad IC; Barkat A; Sefiani A
    BMC Genet; 2014 Dec; 15():156. PubMed ID: 25544508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.